BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/26/2019 8:57:46 AM | Browse: 44 | Download: 24
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 47264
Country of Manuscript Source Taiwan
Received
2019-03-18 05:34
Peer-Review Started
2019-03-20 06:10
To Make the First Decision
2019-06-05 06:35
Return for Revision
2019-06-06 03:46
Revised
2019-06-22 07:34
Second Decision
2019-07-01 00:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-07-17 16:49
Articles in Press
2019-07-17 16:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-08-15 05:57
Publish the Manuscript Online
2019-08-16 00:41
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019 Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Oncology
Manuscript type Minireviews
Article Title Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
Manuscript Source Invited Manuscript
All Author List Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng and Sung-Hsin Kuo
Funding Agency and Grant Number
Funding Agency Grant Number
the Ministry of Science and Technology, Taiwan MOST 107-2314-B-002-217-MY3
National Taiwan University Hospital, Taiwan NTUH 108-S4143
Correspondence To Sung-Hsin Kuo, MD, PhD, Professor, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 100, Taiwan. shkuo101@ntu.edu.tw
Keywords Hepatocellular carcinoma; Proton beam therapy; Carbon ion radiotherapy; Local control; Toxicity; Overall survival
Core Tip Charged particle therapy (CPT) for hepatocelluar carcinoma (HCC), including proton beam therapy and carbon ion radiotherapy, offers physics-related advantages and results in better local control rates and lesser adverse effects. For peripherally large-sized HCC tumors, the hypo-fractionation regimen of CPT provides the benefit of increasing local control rates through overcoming radio-resistance, whereas conventional CPT is preferred for treating central tumors of HCC in terms of avoiding late toxicities of the biliary tract. Prospective data that will add to the accumulated evidence on the dosimetric constraints of hypofractionated CPT for the treatment of HCC are needed.
Publish Date 2019-08-16 00:41
Citation Hsu CY, Wang CW, Cheng AL, Kuo SH. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness. World J Gastrointest Oncol 2019; 11(8): 579-588
Url https://www.wjgnet.com/1948-5204/full/v11/i8/579.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i8.579
Full Article (PDF) WJGO-11-579.pdf
Full Article (Word) WJGO-11-579.docx
Manuscript File 47264-Review.docx
Answering Reviewers 47264-Answering reviewers.pdf
Audio Core Tip 47264-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 47264-Conflict-of-interest statement.pdf
Copyright License Agreement 47264-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 47264-Language certificate.pdf
Peer-review Report 47264-Peer-review(s).pdf
Scientific Misconduct Check 47264-Scientific misconduct check.pdf
Scientific Editor Work List 47264-Scientific editor work list.pdf